Octrooien

Microbubbles for biomedical applications, specifically for use as ultrasonic contrast agents. In particular, the present disclosure relates to a gas-filled microbubble and to a method for fabricating such a gas-filled microbubble.

The present invention is directed to a novel device for measurement of the rigidity and/or tumescence of a penis during a penile tumescent event. In particular, with the device of the present invention both the axial rigidity and the radial rigidity can be monitored and measured continuously, and combined in one measurement device. The device of the present invention therefore comprises axial monitoring means for monitoring the axial rigidity of the penis, and radial monitoring means for monitoring the radial rigidity of the penis.

The present invention is directed to a device for measurement of the rigidity and/or tumescence of a penis during a penile tumescent event. In particular, the device of the present invention comprises axial and/or radial monitoring means for monitoring the axial and/or radial tumescence and/or rigidity of a penis during a penile tumescent event. The present invention further also provides methods for monitoring the axial and/or radial tumescence and rigidity of a penis.

The present invention concerns substituted indoline derivatives, methods to prevent or treat dengue viral infections by using said compounds and also relates to said compounds for use as a medicine, more preferably for use as a medicine to treat or prevent dengue viral infections. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of dengue viral infections. The invention also relates to processes for preparation of the ...

The invention relates to compositions for topical use comprising miconazole or a salt thereof and domiphen bromide as active ingredients for use in treating or preventing a fungal infection.

The present inventive concept relates to a method for forming a pellicle for extreme ultraviolet lithography, the method comprising: forming a coating of a first material on a peripheral region of a main surface of a carbon nanotube pellicle membrane, the membrane including a carbon nanotube film, arranging the carbon nanotube pellicle membrane on a pellicle frame with said peripheral region facing a support surface of the pellicle frame, wherein the support surface of the pellicle frame is formed by a second material, and bonding together the coating of the carbon nanotube pellicle membrane ...

A semiconductor device comprising: i. a first structure (100) made of a first doped semiconductor material of a first doping type, ii. a metal (300) in contact with the first structure (100), and iii. at least a second structure (200) made of a second doped semiconductor material of the first doping type in contact with the first structure (100), wherein a band off-set for majority charge carriers between the first doped semiconductor material and the second doped semiconductor material is sufficiently large for charge carriers from the second doped semiconductor material to be transferred ...

Disclosed is a device, comprising: a first interconnection level (110) including a first dielectric layer (112) and a first set of conductive paths (111) arranged in the first dielectric layer, a second interconnection level (120) arranged on the first connection level and including a second dielectric layer (122) and a second set of conductive paths (121) arranged in the second dielectric layer, a third interconnection level (130) arranged on the second interconnection level and including a third dielectric layer (132) and a third set of conductive paths (131) arranged in the third ...

The application relates to methods of curing retroviral infections, i.e. ensuring remission of retroviral infections, more particularly HIV infections, by administering a compound which is capable of binding to the LEDGF/p75 binding pocket of HIV-integrase and inhibiting LEDGF/p75-IN protein-protein interaction. The application further relates to the use of LEDGINs in retroviral gene therapy.

The patent describes a one-step liquid biphasic catalytic process for converting a carbohydrate-containing feedstock, preferably lignocellulose, to light naphtha (e.g., hexane, pentane, methyl cyclopentane, cyclohexane, etc.) in presence of an acidic reactive aqueous phase and a redox catalyst in the organic extracting/reaction phase. The process provides a cost-effective route for producing light-naphtha components, in presence or not of deoxygenates. The light naphtha components are useful as feedstock for steam and catalytic cracking to produce value-added platform molecules like ethylene ...